Document details

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents

Author(s): Franco Machado, João ; Cordeiro, Sandra ; Duarte, Joana N. ; Costa, Paulo J. ; Mendes, Paulo J. ; Garcia, Maria Helena ; Baptista, Pedro V. ; Fernandes, Alexandra R. ; Morais, Tânia S.

Date: 2024

Persistent ID: http://hdl.handle.net/10362/167690

Origin: Repositório Institucional da UNL

Project/scholarship: info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-QIN%2F0146%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00100%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0056%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04378%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04378%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0140%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50006%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04046%2F2020/PT; info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04046%2F2020/PT; info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F135915%2F2018/PT; info:eu-repo/grantAgreement/FCT/OE/2021.08629.BD/PT; info:eu-repo/grantAgreement/FCT/CEEC IND 2017/CEECIND%2F00630%2F2017%2FCP1387%2FCT0012/PT; info:eu-repo/grantAgreement/FCT/CEEC IND5ed/2022.00028.CEECIND%2FCP1722%2FCT0005/PT; info:eu-repo/grantAgreement/FCT/CEEC IND4ed/2021.00381.CEECIND%2FCP1650%2FCT0004/PT;

Subject(s): Physical and Theoretical Chemistry; Inorganic Chemistry; SDG 3 - Good Health and Well-being


Description

Publisher Copyright: © 2024 The Authors. Published by American Chemical Society.

In recent years, organometallic complexes have attracted much attention as anticancer therapeutics aiming at overcoming the limitations of platinum drugs that are currently marketed. Still, the development of half-sandwich organometallic cobalt complexes remains scarcely explored. Four new cobalt(III)-cyclopentadienyl complexes containing N,N-heteroaromatic bidentate, and phosphane ligands were synthesized and fully characterized by elemental analysis, spectroscopic techniques, and DFT methods. The cytotoxicity of all complexes was determined in vitro by the MTS assay in colorectal (HCT116), ovarian (A2780), and breast (MDA-MB-231 and MCF-7) human cancer cell lines and in a healthy human cell line (fibroblasts). The complexes showed high cytotoxicity in cancer cell lines, mostly due to ROS production, apoptosis, autophagy induction, and disruption of the mitochondrial membrane. Also, these complexes were shown to be nontoxic in vivo in an ex ovo chick embryo yolk sac membrane (YSM) assay.

Document Type Journal article
Language English
Contributor(s) DCV - Departamento de Ciências da Vida; UCIBIO - Applied Molecular Biosciences Unit; RUN
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents